Fareon Open Label Device Clinical Trial

计划入组 30 人 · 首次发布于 2026 年 5 月 20 日

Carbon Dioxide Versus Air Insufflation for the Application of Argon Plasma to Reduce the Gastrojejunal Anastomosis

计划入组 200 人 · 首次发布于 2017 年 8 月 28 日

Study of Enfuvirtide in HIV-Positive Subjects

计划入组 26 人 · 首次发布于 2004 年 7 月 13 日

Falcon

Carbon monoxide

CO

Carbon dioxide

<dd class="col-xl-8 col-md-9 col-sm-8">CO₂</dd>

Faron Pharmaceuticals Oy

Finland

FAGRON

Belgium

Haleon

United Kingdom

Fareon Links Microtesla Magnetic Therapy to Reduced Brain Age and Repair Biomarkers in Long COVID Cognitive Impairment

Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment

Faron Pharmaceuticals Secures €12M to Advance Promising MDS Treatment Bexmarilimab